Incidência de complicações hemorrágicas com o uso de pulseira de compressão radial: estudo de coorte by Córdova, Eliane Silva Machado et al.
1www.ee.usp.br/reeusp Rev Esc Enferm USP · 2018;52:e03410
1 Fundação Universitária de Cardiologia 
do Rio Grande de Sul, Instituto de 
Cardiologia, Porto Alegre, RS, Brazil.
2 Fundação Universitária de Cardiologia do 
Rio Grande de Sul, Instituto de Cardiologia, 
Programa de Residência Multiprofissional 
em Saúde, Porto Alegre, RS, Brazil.
3 Universidade Federal de Ciências da Saúde 
de Porto Alegre, Porto Alegre, RS, Brazil.
ABSTRACT
Objective: To examine the incidence of hemorrhagic complications in patients 
undergoing radial cardiac catheterization and using a hemostatic device for arterial 
compression. Method: A prospective cohort study conducted with patients undergoing 
elective cardiac catheterization in two hemodynamic laboratories in southern Brazil. The 
TR Band® radial compression device was used during 4 hours for hemostasis of the arterial 
puncture site. Hematomas and minor bleeding were the outcomes evaluated. Results: A 
total of 244 patients were evaluated. The mean age was 63.5±10.9 years, 61.9% were 
male, 73.8% had systemic arterial hypertension (SAH) and 42.8% were dyslipidemic. 
Type I hematoma occurred in 1.2% of patients and minor bleeding in 9% after removal 
of the device. There was no significant association between hematomas and bleeding, and 
patients who used oral anticoagulants (p=0.604) and prior use of antiplatelets (p=0.958). 
Conclusion: The use of the hemostatic device for radial artery compression was safe in 
clinical practice and there was a low incidence of hematomas and minor bleeding after 
radial coronary angiography.
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INTRODUCTION
The radial pathway has been widely used in percuta-
neous cardiovascular procedures, since it allows perform-
ing complex interventions with reduction of intensity and 
duration of hemostasis after arterial pressure, and is associ-
ated with lower rates of vascular complications and major 
bleedings with potential impact on morbidity and mortal-
ity(1-4). Another important factor of this approach is the 
preferential choice by patients, because it provides greater 
comfort in recovery after the intervention by enabling early 
ambulation and shorter hospitalization time(5-6). However, 
the small caliber of the artery makes puncture difficult 
and requires a longer learning curve compared to femoral 
access, but these challenges are often overcome with opera-
tors’ experience(7-8). Vascular complications and radial artery 
occlusion (RAO) are some of the reported complications 
that may predispose the patient to extremity ischemia. 
However, occurrences of this magnitude are infrequent and 
should not be considered limiting. Data from the literature 
describe a low incidence of RAO when diagnosed clinically 
or by ultrasound(1,9-10). Multiple radial artery catheteriza-
tions, larger doses of heparin, longer compressions, and 
use of a larger caliber introducer are the most common 
predisposing factors for these complications(11). Another 
concern in the interventional practice, although smaller, is 
the duration of bleeding and the delay of hemostasis after 
arterial compression.
Among the available methods of radial compres-
sion widely used in hemodynamics laboratories, there is 
manual compression, the use of occlusive dressings with 
elastic bandage and hemostatic devices. These may reduce 
the time to reach hemostasis and prevent complications 
related to arterial patency. Previous studies comparing 
compression devices of the arterial puncture site between 
patients undergoing percutaneous procedures indicate 
a slightly higher incidence of bleeding and hematoma 
with use of compression dressings compared to hemo-
static devices, without prejudice to the patency of the 
artery used and without prolonging hospital stay(12-13). The 
TR Band® radial compression device was developed by 
Terumo Medical, is easy to handle, hygienic and reusable, 
an advantage in reducing hospital costs compared to other 
compression techniques(10).
The different methods and devices available have been 
well accepted in clinical practice. However, each service 
or team seeks to develop safe and effective strategies 
according to their reality and availability. Thus, sharing 
systematized care practices in the interventionist cardiol-
ogy scenario can contribute to improvements in care lines 
involving patients undergoing percutaneous intervention 
with repercussions on quality and care safety. In light of 
the above and the need to evaluate a new technology 
handled by nursing, this study was designed for checking 
the incidence of hemorrhagic complications in patients 




Prospective, non-comparative cohort study.
populaTion
Patients of both sexes, aged 18 years or older, who under-
went elective cardiac catheterization (elective coronary angi-
ography) with an initial radial airway approach, and used the 
TR Band® hemostatic device were included. Patients who 
underwent angioplasty soon after the diagnostic examina-
tion were excluded.
scenario
The study was conducted in two hemodynamic 
laboratories in southern Brazil. One of these laborato-
ries provides public and private health care, is located 
in the northeast region of Rio Grande do Sul, and has 
five hemodynamic doctors and two nurses. The other is 
located in the region of Planalto Catarinense, provides 
private health care exclusively, and has two hemodynamic 
doctors and one nurse.
sample calculaTion
The sample size calculation was based on a previous 
study(12), in which there was a 3.4% incidence of hemorrhagic 
complications. The following were considered: 95% confi-
dence interval, a margin of error of 1.5%, and an approximate 
population of 400 patients/year. It was estimated a need to 
evaluate 234 patients (including 20% of losses).
daTa collecTion
Subjects were included in the study after the diagnostic 
examination, when they accepted to participate. After the 
end of cardiac catheterization, the hemodynamicist applied 
the hemostatic device while in the hemodynamics room, 
removed the introducer and inflated the air bladder accord-
ing to manufacturer’s guidelines (15 ml of air). Patients 
remained with the compression device for 4 hours (time rec-
ommended by the manufacturer) outside the hemodynamics 
room, seated in reclining seats. After the 3rd hour, started the 
air bladder deflation by keeping it connected to the plunger, 
controlling the plunger with the thumb, and observing the 
puncture site. The total time for deflation was 1 hour, since 
every 15 minutes, 4 ml of air were deflated, and in the last 
15 minutes, the remaining 3 ml of air. As the device was 
transparent, the puncture site could be visualized hourly. 
During this period until complete removal of the device, 
was evaluated the occurrence of hemorrhagic complications. 
Once hemostasis was reached after the 4th hour, the device 
was removed, and patients were released home.
In all patients included in this study for elective exams 
(cardiac catheterization), were used 5F or 6F introduc-
ers, 5,000 IU of heparin and 70 ml of non-ionic contrast 
agent - Iopamiron 370®.
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The independent variables evaluated were age, weight, 
sex, comorbidities (systemic arterial hypertension, diabetes 
mellitus, dyslipidemia, previous acute myocardial infarc-
tion, previous cerebrovascular accident, chronic obstructive 
pulmonary disease, chronic renal failure, peripheral obstruc-
tive arterial disease), previous use of oral anticoagulant, oral 
antiplatelet, caliber of introducer caliber, number of use of 
devices, procedure time.
ouTcomes and follow-up
The outcomes evaluated were the occurrence of hem-
orrhagic complications, namely hematomas and minor 
bleeding. Hematomas were classified as type I (≤ 5 cm 
diameter); type II (≤ 10 cm diameter), type III (> 10 cm, 
without reaching the elbow); type IV (hematoma extend-
ing beyond the elbow); and type V (any hematoma with 
ischemic injury of the hand)(14). Minor bleeding was any 
visible sign of blood during use and at the time of removal 
of the radial compression device (TR Band®). In case of 
minor bleeding during the first 3 hours of wearing the 
device, was added a further 1 ml of air, and normally per-
forming deflation in the 3rd hour. The success of the device 
was defined as obtaining adequate hemostasis at the end 
of the procedure with the TR Band® device with no need 
for conversion to compression dressing with elastic ban-
dage(10). The follow-up was performed from application of 
the device to its removal. All patients were followed up by 
the service nurse, who performed the deflation, monitor-
ing and removal of the device. In case of minor bleeding 
during the initiation of deflation (3rd hour) and removal of 
the device (4th hour), air was again inflated until reaching 
15 ml, and after 1 hour, the deflation started again with 
the same scheme as previously mentioned.
analysis and processing of daTa
Statistical analyzes were performed with the Statistical 
Package for Social Sciences (SPSS), version 22.0. Categorical 
variables were expressed as absolute numbers (n) and per-
centages (%), and continuous variables were expressed as 
mean±standard deviation for those with normal or median dis-
tribution and interquartile range. In order to find associations 
between the variables, was used the chi-square test, and for the 
association between the independent variables and the occur-
rence of grouped outcomes (hematoma plus minor bleeding) 
was performed the unadjusted univariate logistic regression.
eThical aspecTs
The research project was approved by the Research Ethics 
Committee of institutions under number 1.338.057, year 
2015, according to resolution 466/12. All patients signed 
the Informed Consent form.
RESULTS
A total of 244 patients were included, of which 62.0% 
were male, and the mean age was 63.5±10.9 years. Table 
1 shows the sociodemographic and clinical characteristics 
of the sample, and the most prevalent comorbidities were 
systemic arterial hypertension (180; 73.8%) and dyslipid-
emia (140; 42.8). In most patients, was used the 5F intro-
ducer (63.9%). The mean reuse of the TR Band® device 
was 23.42±17.05, and new devices were used in 14 (5.7%) 
patients. Regarding the duration of the examination, in 215 
(88.1%) patients, it was up to 30 minutes.
Table 1 – Sociodemographic and clinical characteristics – Porto 
Alegre, RS, Brazil, 2016.
Variables n (%)
Male sex 151 (61.9)
Age* 63.5 ± 10.9
Systemic arterial hypertension 180 (73.8)
Dyslipidemia 140 (42.8)
Diabetes Mellitus 85 (34.8)
Prior cerebral vascular accident 16 (6.6)
Acute myocardial infarction 33 (13.5)
Chronic renal failure 3 (1.2)
Chronic obstructive pulmonary disease 4 (1.6)
Peripheral arterial obstructive disease 6 (2.5)
Prior use of oral anticoagulant 6 (2.5)
Prior use of antiplatelet 155 (63.5)
*Variable presented with mean/standard deviation.
Note: (n=244).
hemorrhagic complicaTions
Regarding the outcomes evaluated, 25 patients (10.2%) 
had hemorrhagic complications, with a predominance of 
minor bleeding during deflation of the device (3rd hour) 
in seven (2.8%) patients, and during removal of the device 
(4th hour) in 15 (6.2%) patients. These and other data are 
shown in Table 2.
Table 2 – Complications with the use of radial compression de-
vices – Porto Alegre, RS, Brazil, 2016. 
Hemorrhagic complications n (%)
Type I hematoma 3 (1.2)
Minor bleeding 22 (9.0)
During first 3 hours of use 7 (2.8)
3rd hour (during deflation and removal of device) 15 (6.2)
Note: (n=244).
There was no significant association between the most 
prevalent comorbidity in the sample (SAH – systemic arte-
rial hypertension), the procedure time, the use of oral anti-
coagulant or antiplatelet and the incidence of hemorrhagic 
complications due to use of the TR Band® (data presented 
in Table 3).
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Table 3 – Association between independent variables and hem-








Yes 18 (10.0) 0.90 (0.37-2.42) 0.832
No 7 (10.9) 1.00
Procedure time
<30 min 21 (9.8) 1.00
30-60 min 4 (13.8) 1.4 (0.40-4.27) 0.505
Prior use of OAC
Yes 1(16.7) 1.78 (0.09-11.67) 0.604
No 24 (10.1) 1.00
Prior use of antiplatelet
Yes 16 (10.3) 1.02 (0.44-2.51) 0.958
No 9 (10.1) 1.00
SAH: systemic arterial hypertension; OAC: oral anticoagulant; OR: 
odds ratio; CI: confidence interval.
DISCUSSION
The use of radial access is recognized as a safe way of 
performing cardiac diagnostic catheterization and percuta-
neous coronary interventions (PCI), and in the literature, 
different compression methods for hemostasis have been 
described(1,3-4). The present study examined the incidence of 
hemorrhagic complications in patients undergoing radial 
cardiac catheterization with use of a hemostatic device for 
radial compression during a 4-hour period. The knowledge 
of results achieved with new devices that are also handled 
by nurses with different deflation schemes is relevant for 
better defining the care actions, since these professionals 
are directly involved in the monitoring and evaluation of 
the puncture site after the procedure.
In a sample mostly composed of elderly men with SAH, 
the results of this study showed the use of a compression 
device is safe in relation to the incidence of type I hemato-
mas (1.2%) and minor bleedings (9.0%). The previous use 
of oral anticoagulant and antiplatelets did not influence 
the outcomes in the studied sample. In a previous study in 
which was evaluated hemostasis with use of the TR Band® 
device after radial puncture in patients with acute coronary 
syndrome and similar sociodemographic characteristics to 
this study, the incidence of hematoma was 3.4% (all type II)
(1). In another study, were compared two radial compression 
devices in patients after percutaneous coronary intervention, 
and was found that 20% of those using the TR Band® device 
presented minor bleeding(15). Furthermore, the patients eval-
uated in our study underwent only a coronary diagnostic 
procedure, and generally, with a shorter duration than PCI.
Hemostasis obtained by pneumatic pressure of the device 
applied directly to the radial artery site has proved to be use-
ful and easy to handle, in addition to allowing visualization 
of the puncture site, because the material is transparent. 
Equally important are the comfort and shorter recovery time 
of patients when using the radial access route, since they can 
move even with restricted movement of the catheterized 
upper limb.
Different compression devices are offered by the special-
ized industry. However, the quality of the product should be 
combined with patients’ comfort and safety. A randomized 
clinical trial conducted with 790 patients compared two 
methods of radial compression. The results showed there 
were less reports of pain at the puncture site in patients 
using the TR Band® device compared to the group using the 
Radistop device of radial artery compression that is some-
what larger than the device (77% vs. 61%; P=0.0001). In 
addition, the time to reach hemostasis was lower in the group 
using the TR Band® (5.32±2.29 vs. 4.83±2.23 h; p=0.004). 
However, both devices were effective and safe for hemostatic 
compression(16). Health teams must be particularly atten-
tive to the female sex (lower wrist diameter than that of 
men), length of stay of the introducer and higher pressure 
volume, since these factors have been associated with the 
presence of bruising and pain at the arterial puncture site(17). 
It is important to remember that the air volume pushed 
into the bladder of the device must be adjusted according 
to the manufacturer’s instruction (15 ml), but there is no 
standardized information on the compression time. In a 
recent study, were evaluated three different intensities and 
compression periods. The results showed that a short period 
of 90 minutes of compression and the injection of less air 
than recommended (10 ml) were sufficient for hemostasis(18).
Recent data point to considering hemostatic devices as 
an economical and simple method of therapeutic option 
and non-invasive treatment of vascular complications, such 
as pseudoaneurysm and arteriovenous fistula(19-20). Another 
feature of the compression device is that it can be reused sev-
eral times, although a little more costly. The elastic bandage, 
in turn, is more economical, but disposable, that is, single use.
Maintaining arterial patency during hemostasis is the 
most important parameter for reducing the risk of arte-
rial occlusion, which is one of the most concerning com-
plications for the team. In spite of the low occurrence of 
this complication, data from the literature show it ranges 
between 1% and 10% in patients undergoing percutaneous 
coronary procedures(9). In a randomized study involving 400 
diagnostic coronary procedures, the incidence of early radial 
occlusion was 7%, and of late occlusion was 5%(21). During 
the hemostasis process with use of the TR Band® device, 
the careful observation, prompt detection of hematoma and 
adequate handling of the device performed by nursing are 
key for avoiding further complications. This device allows 
flexibility in the inflation process, time of permanence and 
deflation, so that each service can adopt one of the more 
evidence-based strategies in relation to safety. New compara-
tive studies, either with control group, or with other devices 
used for radial compression, are needed in order to ratify the 
device safety and present other deflation schemes.
Among the limitations of this study, there is the fact that 
ultrasonography was not performed for evaluation of arte-
rial patency after device use, as well as the lack of a patient 
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control group, since the device was used in all patients 
undergoing percutaneous radial procedure.
CONCLUSION
The use of the hemostatic device for radial artery com-
pression during a 4-hour period proved to be safe in clinical 
practice and with a low incidence of hemorrhagic complica-
tions after elective cardiac catheterization. The contribution 
of this study to nursing care practice is presenting the results 
of a strategy of using a device after percutaneous procedures 
in cardiology. The results of this longitudinal study can sup-
port nurses’ decision-making in their daily work.
RESUMO 
Objetivo: Verificar a incidência de complicações hemorrágicas em pacientes submetidos a cateterismo cardíaco radial e com uso de 
pulseira hemostática para compressão arterial. Método: Estudo de coorte prospectivo, conduzido com pacientes submetidos a cateterismo 
cardíaco eletivo, em dois laboratórios de hemodinâmica no sul do Brasil. Para a hemostasia do sítio de punção arterial, foi utilizada a 
pulseira de compressão radial TR Band® por 4 horas. Os desfechos avaliados foram hematomas e sangramento menor. Resultados: 
Foram avaliados 244 pacientes, com idade média de 63,5±10,9 anos, 61,9% do sexo masculino, 73,8% com hipertensão arterial sistêmica 
e 42,8% dislipidêmicos. Ocorreram 1,2% de hematoma tipo I e 9% de sangramento menor depois da retirada da pulseira. Não houve 
associação significativa entre hematomas e sangramentos e os pacientes que faziam uso de anticoagulante oral (p=0,604) e uso prévio 
de antiplaquetário (p=0,958). Conclusão: O uso da pulseira hemostática para compressão da artéria radial mostrou-se segura na prática 
clínica e com reduzida incidência de hematomas e sangramento menor após cinecoronariografia por via radial.
DESCRITORES
Cateterismo Cardíaco; Hemodinâmica; Artéria Radial; Enfermagem Cardiovascular.
RESUMEN
Objetivo: Verificar la incidencia de complicaciones hemorrágicas en pacientes sometidos a cateterismo cardiaco radial y con el uso de 
pulsera hemostática para compresión arterial. Método: Estudio de cohorte prospectivo, conducido con pacientes sometidos a cateterismo 
cardiaco electivo, en dos laboratorios de hemodinámica en el sur de Brasil. Para la hemostasia del sitio de punción arterial, se utilizó 
la pulsera de compresión radial TR Band® por 4 horas. Los resultados evaluados fueron hematomas y sangrado menor. Resultados: 
Fueron evaluados 244 pacientes, con edad media de 63,5±10,9 años, el 61,9% del sexo masculino, el 73,8% con hipertensión arterial 
sistémica y el 42,8% dislipidémicos. Ocurrió el 1,2% de hematoma tipo I y el 9% de sangrado menor después de la retirada de la pulsera. 
No hubo asociación significativa entre hematomas y sangrados y los pacientes que hacían uso de anticoagulante oral (p=0,604) y uso 
previo de antiplaquetario (p=0,958). Conclusión: El uso de la pulsera hemostática para compresión de la arteria radial se mostró segura 
en la práctica clínica y con reducida incidencia de hematomas y sangrado menor luego de cinecoronariografía por vía radial.
DESCRITORES
Cateterismo Cardíaco; Hemodinámica; Arteria Radial; Enfermería Cardiovascular.
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